Stay updated with breaking news from Team Summit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Summit Therapeutics (SMMT) stock gained as its lead asset, ivonescimab, surpassed Merck's (MRK) Keytruda, marking a first in lung cancer. Read more here.
Summit Therapeutics Inc. reports earnings inline with expectations. Reported EPS is $-0.06 EPS, expectations were $-0.06.
On Sunday, April 28, Team Summit announced that former Alpine ski athlete Stanley Buzek has been named Alpine Rookie of the Year by U.S. Ski and Snowboard. Prior to being named to the Stifel U.S....
Siblings of AVSC’s first duo to go to freeride worlds cap first-place seasons
Today on THE WARMUP: We’re talking with two of the rippingest young skiers on Team Summit. Ask Emma Litwiller what she loves about big-mountain skiing, and she’ll think for a second, before shyly giving you the only correct answer. “I like face shots,” Emma tells Krystal 93 news director Phil Lindeman. “I like going off